• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands
In conclusion, this study presents HRQoL scores using different instruments and detailed loss of productivity estimates for breast cancer patients treated with adjuvant endocrine therapy. The results presented here can be used to inform input parameters in health economic evaluations of interventions for patients with breast cancer in the Netherlands and other Western countries and ultimately support decision making.PMID:36584427 | DOI:10.1016/j.biopha.2022.114158
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - December 30, 2022 Category: Drugs & Pharmacology Authors: Anne Kleijburg C Louwrens Braal Justin D Westenberg Agnes Jager Stijn L W Koolen Ron H J Mathijssen Carin A Uyl-de Groot Pim Wetzelaer Hannah Penton Source Type: research

Cell-based therapy in thin endometrium and Asherman syndrome
Stem Cell Res Ther. 2022 Jan 28;13(1):33. doi: 10.1186/s13287-021-02698-8.ABSTRACTNumerous treatment strategies have so far been proposed for treating refractory thin endometrium either without or with the Asherman syndrome. Inconsistency in the improvement of endometrial thickness is a common limitation of such therapies including tamoxifen citrate as an ovulation induction agent, acupuncture, long-term pentoxifylline and tocopherol or tocopherol only, low-dose human chorionic gonadotropin during endometrial preparation, aspirin, luteal gonadotropin-releasing hormone agonist supplementation, and extended estrogen therapy....
Source: Cell Research - January 29, 2022 Category: Cytology Authors: Nastaran Gharibeh Leili Aghebati-Maleki Javad Madani Ramin Pourakbari Mehdi Yousefi Javad Ahmadian Heris Source Type: research

Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark
CONCLUSIONS: Low SEP in premenopausal women with non-metastatic breast cancer was associated with increased mortality, but not always recurrence. This suggests underdetection of recurrences in certain groups. Poor prognosis in women with low SEP, especially single women, may partly be explained by tamoxifen adherence.PMID:34587961 | DOI:10.1186/s12916-021-02108-z
Source: Clinical Genitourinary Cancer - September 30, 2021 Category: Cancer & Oncology Authors: Cathrine Fonnesbech Hjorth Per Damkier Bent Ejlertsen Timothy Lash Henrik Toft S ørensen Deirdre Cronin-Fenton Source Type: research